EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+8.79%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.67B
AUM Growth
+$449M
(+8.6%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
21.33%
Holding
988
New
29
Increased
183
Reduced
116
Closed
41
Top Buys
| 1 |
AstraZeneca
AZN
|
$42.8M |
| 2 |
Xylem
XYL
|
$37.5M |
| 3 |
Arch Capital
ACGL
|
$36.9M |
| 4 |
Ametek
AME
|
$13.1M |
| 5 |
W.W. Grainger
GWW
|
$12.7M |
Top Sells
| 1 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
$37.3M |
| 2 |
Intuit
INTU
|
$32.4M |
| 3 |
Progressive
PGR
|
$31.2M |
| 4 |
Victoria's Secret
VSCO
|
$24.5M |
| 5 |
NVIDIA
NVDA
|
$11.1M |
Sector Composition
| 1 | Technology | 32.22% |
| 2 | Healthcare | 19.27% |
| 3 | Consumer Discretionary | 10.8% |
| 4 | Industrials | 9.16% |
| 5 | Financials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Pacific Biosciences
PACB
$381M
| $833K | 0.01% |
63,500
-35,000
| -36% | -$459K |
|
377
Ocular Therapeutix
OCUL
$2.37B
| $805K | 0.01% |
158,800
| – | – |
|
378
Axsome Therapeutics
AXSM
$6.25B
| $804K | 0.01% |
11,000
| – | – |
|
|
DCBO
379
Docebo
DCBO
$896M
| $804K | 0.01% |
20,900
| – | – |
|
380
Nutrien
NTR
$27.4B
| $797K | 0.01% |
13,500
+5,400
| +67% | +$319K |
|
381
Becton Dickinson
BDX
$55.1B
| $793K | 0.01% |
3,042
+514
| +20% | +$134K |
|
382
Denali Therapeutics
DNLI
$2.26B
| $790K | 0.01% |
26,900
| – | – |
|
383
GeoPark
GPRK
$326M
| $788K | 0.01% |
80,000
| – | – |
|
384
Franco-Nevada
FNV
$37.3B
| $780K | 0.01% |
5,611
+5,400
| +2,559% | +$751K |
|
385
Vir Biotechnology
VIR
$732M
| $719K | 0.01% |
28,800
| – | – |
|
386
Sociedad Química y Minera de Chile
SQM
$13.1B
| $715K | 0.01% |
10,000
| – | – |
|
387
Ultragenyx Pharmaceutical
RARE
$3.07B
| $700K | 0.01% |
15,010
| – | – |
|
388
Prudential Financial
PRU
$37.2B
| $697K | 0.01% |
7,932
-40,445
| -84% | -$3.55M |
|
389
Box
BOX
$4.75B
| $694K | 0.01% |
23,900
| – | – |
|
390
Hartford Financial Services
HIG
$37B
| $692K | 0.01% |
9,700
| – | – |
|
391
Beam Therapeutics
BEAM
$2.11B
| $690K | 0.01% |
21,700
| – | – |
|
392
Celanese
CE
$5.34B
| $685K | 0.01% |
6,000
+1,500
| +33% | +$171K |
|
393
Legend Biotech
LEGN
$6.66B
| $681K | 0.01% |
9,700
| – | – |
|
394
Tencent Music
TME
$37.7B
| $664K | 0.01% |
90,000
| – | – |
|
395
Elevance Health
ELV
$70.6B
| $656K | 0.01% |
1,489
-7,141
| -83% | -$3.15M |
|
396
Regal Rexnord
RRX
$9.66B
| $650K | 0.01% |
4,295
+1,871
| +77% | +$283K |
|
397
Day One Biopharmaceuticals
DAWN
$773M
| $628K | 0.01% |
51,200
| – | – |
|
398
Krystal Biotech
KRYS
$4.35B
| $625K | 0.01% |
5,400
| – | – |
|
399
Kymera Therapeutics
KYMR
$3.11B
| $605K | 0.01% |
27,000
| – | – |
|
400
Cytokinetics
CYTK
$6.34B
| $604K | 0.01% |
18,450
| – | – |
|